TAK

Takeda Pharmaceutical Company Limited
D

TAK

14.560
USD
0.13
(0.90%)
مغلق
حجم التداول
83,326
الربح لكل سهم
132
العائد الربحي
2.24
P/E
32
حجم السوق
45,480,727,481
أصول ذات صلة
AZN
AZN
-0.110
(-0.16%)
70.410 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
JNJ
JNJ
0.360
(0.24%)
152.930 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVO
NVO
-1.700
(-2.46%)
67.310 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
SNY
SNY
-0.515
(-0.98%)
51.995 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.